GEODE CAPITAL MANAGEMENT, LLC

Position in SRZN — Surrozen, Inc./DE

CIK 1214717 BOSTON, MA

Position in SRZN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,918,180

+$404,094 QoQ

Shares Held

65,849

-1.7% QoQ

Ownership

0.567%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#24

of 58 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $18,580,924,343 across 526 Biotechnology names. SRZN ranks #272 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,139,621	$2,741,586,360
2	REGN	Regeneron Pharmaceuticals, Inc.	2,607,732	$2,014,838,051
3	ALNY	Alnylam Pharmaceuticals, Inc.	2,660,385	$880,241,584
4	INSM	INSMED Inc	4,450,389	$727,727,608
5	MRNA	Moderna, Inc.	9,435,132	$479,304,705
6	INCY	Incyte Corp	4,703,184	$442,663,677
7	RPRX	Royalty Pharma plc	7,869,632	$377,506,246
8	BBIO	BridgeBio Pharma, Inc.	4,918,030	$365,212,906

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,918,180	65,849	-1.7%	Shares	Defined	2026-05-15
2025-12-31	$1,514,086	66,995	+22.9%	Shares	Defined	2026-02-09
2025-09-30	$702,579	54,527	+76.1%	Shares	Defined	2025-11-12
2025-06-30	$276,808	30,963	+22.6%	Shares	Defined	2025-08-08
2025-03-31	$294,542	25,261	+12.8%	Shares	Defined	2025-05-13
2024-12-31	$321,310	22,391	+26.1%	Shares	Defined	2025-02-12
2024-09-30	$212,776	17,761	-5.1%	Shares	Defined	2024-11-12
2024-06-30	$204,851	18,708	+63.1%	Shares	Defined	2024-08-09
2024-03-31	$180,240	11,473	0.0%	Shares	Defined	2024-05-13
2023-12-31	$107,846	11,473	—	Shares	Defined	2024-02-13
No filing history on record for this holder in this stock.